|
Online Database of Chemicals from Around the World | Search | Submit | Advertise |
Home >> Chemical Listing >> Vosaroxin>> Market Analysis Reports |
Market Analysis Reports of Vosaroxin |
|
Therapeutic Class Overview: Treating Refractory Hematological Malignancies Targeting unmet needs in the treatment of cancer/ hematological malignancies through innovative drug development strategies have witnessed favorable outcomes. Over the past decade, Proteasome inhibitor, Velcade (bortezomib) and the immunomodulatory drugs ... Acute Myeloid Leukemia (AML) Therapeutics: Market Research Report This report analyzes the worldwide markets for Acute Heart Failure (AHF) Therapeutics in US$ Thousand. The report provides separate comprehensive analytics for the US, Japan, Europe, and Rest of World. Annual estimates and forecasts are provided for the ... Sunesis Pharmaceuticals Inc (VIRX) - Financial and Strategic SWOT Analysis Review ... TAK-580 (formerly MLN2480) and Vosaroxin for the treatment of various types ... Sunesis Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report ... . The company's major products include Vosaroxin, TAK-580, SSN-510 and ... |